Yin Gu

697 total citations
23 papers, 491 citations indexed

About

Yin Gu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yin Gu has authored 23 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Yin Gu's work include Protease and Inhibitor Mechanisms (6 papers), Cancer Cells and Metastasis (3 papers) and Immune Response and Inflammation (3 papers). Yin Gu is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Cancer Cells and Metastasis (3 papers) and Immune Response and Inflammation (3 papers). Yin Gu collaborates with scholars based in United States, China and Switzerland. Yin Gu's co-authors include Lars Karlsson, Siquan Sun, Robin L. Thurmond, James P. Edwards, Marco Colonna, Anja Fuchs, Wai‐Ping Fung‐Leung, Navin Rao, Miguel A. F. Sanjuán and Wen Jiang and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Yin Gu

23 papers receiving 480 citations

Peers

Yin Gu

IMMUN

ONCOL

Kévin Ly Canada

Laia Rosich Spain

Patty Trobridge United States

Keman Zhang United States

Tomoko Smyth United Kingdom

Jorg Michels Canada

Sachiko Tai Japan

Indranil Basu United States

Francisco J. Cimas Spain

Karla D'Alessio United States

Kévin Ly Canada

Yin Gu

218 ×1.0

119 ×0.7

IMMUN

74 ×0.5

ONCOL

103 ×1.1

13 ×0.4

Citations per year, relative to Yin Gu Yin Gu (= 1×) peers Kévin Ly

Countries citing papers authored by Yin Gu

Since Specialization

Citations

This map shows the geographic impact of Yin Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yin Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yin Gu more than expected).

Fields of papers citing papers by Yin Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yin Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yin Gu. The network helps show where Yin Gu may publish in the future.

Co-authorship network of co-authors of Yin Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Yin Gu. A scholar is included among the top collaborators of Yin Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yin Gu. Yin Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Bao, et al.. (2025). A fully integrated microfluidic cartridge for rapid and ultrasensitive nucleic acid detection from oropharyngeal swabs. Lab on a Chip. 25(3). 454–464. 1 indexed citations

Guibinga, Ghiabe-Henri, et al.. (2024). Comparative assessment of the transduction efficiency and safety associated with the delivery of AAV9-GFP vector via lumbar puncture to cynomolgus macaques with and without anti-AAV9 pre-existing antibodies. Molecular Therapy — Methods & Clinical Development. 32(4). 101371–101371. 1 indexed citations

Lin, Baobao, Bao Li, Wu Zeng, et al.. (2024). Needle‐Plug/Piston‐Based Modular Mesoscopic Design Paradigm Coupled With Microfluidic Device for Point‐of‐Care Pooled Testing. Advanced Science. 11(42). e2406076–e2406076. 5 indexed citations

Jiao, Tingting, et al.. (2024). In Situ Colorimetric LAMP Based on One-Step Modified Filter Paper to Screen Human Papillomavirus (HPV)16/18 from Clinical Samples. Langmuir. 40(32). 16722–16730. 1 indexed citations

Li, Bao, Baobao Lin, Yan Wang, et al.. (2024). Multi-scenario surveillance of respiratory viruses in aerosols with sub-single-copy spatial resolution. Nature Communications. 15(1). 8770–8770. 12 indexed citations

Liu, Peng, et al.. (2020). TRIM52 positively mediates NF-κB to promote the growth of human benign prostatic hyperplasia cells through affecting TRAF2 ubiquitination. Life Sciences. 259. 118380–118380. 5 indexed citations

Kashyap, Manoj Kumar, Deepak Kumar, Brett H. Simmons, et al.. (2017). Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia. Journal of Hematology & Oncology. 10(1). 112–112. 49 indexed citations

Zhang, Yanyan, Ruoping Tang, Yin Gu, et al.. (2017). Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143). Scientific Reports. 7(1). 7305–7305. 31 indexed citations

Fang, Douglas D., Cathy C. Zhang, Yin Gu, et al.. (2013). Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation. PLoS ONE. 8(6). e67258–e67258. 33 indexed citations

10.

Fang, Douglas D., Joan Cao, Jitesh P. Jani, et al.. (2013). Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line. Frontiers of Medicine. 7(4). 462–476. 15 indexed citations

11.

Xu, Yan, Gang Zhao, Yong Cai, et al.. (2012). Survival Benefit of Traditional Chinese Herbal Medicine (a Herbal Formula for Invigorating Spleen) for Patients With Advanced Gastric Cancer. Integrative Cancer Therapies. 12(5). 414–422. 35 indexed citations

12.

Ameriks, Michael K., Scott D. Bembenek, Matthew Burdett, et al.. (2010). Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(14). 4060–4064. 16 indexed citations

13.

Ameriks, Michael K., Frank U. Axe, Scott D. Bembenek, et al.. (2009). Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements. Bioorganic & Medicinal Chemistry Letters. 19(21). 6131–6134. 18 indexed citations

14.

Ameriks, Michael K., James P. Edwards, Yin Gu, et al.. (2009). Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: Optimization of cellular potency. Bioorganic & Medicinal Chemistry Letters. 19(21). 6135–6139. 11 indexed citations

15.

Wei, Jianmei, Barbara Pio, Siquan Sun, et al.. (2007). Pyrazole-based cathepsin S inhibitors with improved cellular potency. Bioorganic & Medicinal Chemistry Letters. 17(20). 5525–5528. 20 indexed citations

16.

Xue, Xiaohua, et al.. (2006). Anti-Inflammatory Activity in Vitro and in Vivo of the Protein Farnesyltransferase Inhibitor Tipifarnib. Journal of Pharmacology and Experimental Therapeutics. 317(1). 53–60. 33 indexed citations

17.

Grice, Cheryl A., Haripada Khatuya, Darin J. Gustin, et al.. (2006). The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(8). 2209–2212. 10 indexed citations

18.

Sanjuán, Miguel A. F., Navin Rao, Yin Gu, et al.. (2006). CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. The Journal of Experimental Medicine. 203(4). i13–i13. 3 indexed citations

19.

Gustin, Darin J., Clark A. Sehon, Jianmei Wei, et al.. (2005). Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(6). 1687–1691. 32 indexed citations

20.

Thurmond, Robin L., Siquan Sun, Clark A. Sehon, et al.. (2004). Identification of a Potent and Selective Noncovalent Cathepsin S Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 308(1). 268–276. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact